Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal cell surface glycans and their associated receptors constitute the glycocalyx, a complex carbohydrate-rich layer that coats the surface of retinal neurons, glial cells, and the retinal pigment epithelium (RPE). These molecules, including heparan sulfate proteoglycans, sialic acids, and specific N-linked glycans, play critical roles in maintaining retinal architecture, facilitating cell-cell communication, and regulating the assembly of photoreceptor outer segments (Jablonski et al., 2019; Creative Biolabs). A notable specific target within this category is the retinal glycan-binding receptor expressed on Müller cells, which interacts with multivalent N-linked glycans to promote photoreceptor survival and structural integrity (Jablonski et al., 2019). In the context of therapeutic development, these glycans serve as primary attachment factors for adeno-associated virus (AAV) vectors used in gene therapy, determining the efficiency and specificity of viral entry (Frontiers in Pharmacology). Synthetic glycans like NA3 (asialo-, tri-antennary complex-type N-glycan) are being investigated as neuroprotective agents for atrophic age-related macular degeneration (AMD) and retinitis pigmentosa (Jablonski et al., 2019). Alterations in retinal glycosylation patterns are associated with various degenerative diseases, making these surface molecules key targets for both drug delivery and direct therapeutic intervention (BrightFocus Foundation).
Receptor ligation to promote photoreceptor outer segment assembly; Viral attachment and entry via glycan binding; Modulation of the innate immune system through complement factor interaction
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal cell surface glycans.